As of February 13, 2026, shares of Eli Lilly (NYSE:LLY) were trading at $1,040, just 5.8% below the stock’s all-time high. Retail sentiment has turned decisively bullish following the company’s Q4 ...

Eli Lilly announced an acquisition of an innovative new autoimmune drug.

This history of rapid acceleration suggests that Eli Lilly is primed for another massive breakout as new catalysts emerge.

Mounjaro and Zepbound generated a combined $11.7 billion in sales for the company in its most recent quarter.

Feb 12 (Reuters) - Eli Lilly ⁠had $1.5 ⁠billion worth of ⁠pre-launch inventory of its experimental oral ​weight-loss drug, a ...

Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit ...

As with so much of Lilly’s recent advertising work, Wieden+Kennedy’s specific style and tone have helped differentiate its commercials from that of other pharma companies.

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...

Pharmaceutical giant Eli Lilly announced in December at a program at the Von Braun Center that it plans to invest $6 billion in a Huntsville campus and create 450 high-paying jobs. The campus will be ...

Novo Nordisk (NVO) stock will produce Wegovy pills in Ireland after attracting 240,000 users in five weeks as CEO battles Eli ...

It's the latest in a string of science-focused deals that the pharmaceutical giant has made over the past 12 months as its ...

The Huntsville City Council approved a $6 billion manufacturing plant for pharmaceutical giant Eli Lilly that will bring ...